Novartis Investigator Site

Rozzano

0 studies enrolling now · 2 studies all time

What they study most

COPD, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed